Johns Hopkins is home to one of the largest leukemia programs worldwide. Our researchers are covering groundbreaking treatments in all types of leukemias and blood disorders. Leukemia is a cancer of the blood cells, which are produced in the bone marrow -- the spongy interior of the bones. Normally, blood cells are made in an orderly, controlled way. When leukemia develops, the bone marrow produces abnormal cells; therefore, the cells that are responsible for fighting infections and preventing bleeding are not made correctly.

  • Our Team

    Leukemia experts at Johns Hopkins are world-renowned for their experience in the treatment and management of leukemia and blood disorders.

  • Treatment Options

    After reviewing your lab results and accurately diagnosing your stage of leukemia, Johns Hopkins Kimmel Cancer Center will design a treatment plan tailored for each patient, based on their age, symptoms and type of leukemia.

  • Clinical Trials

    Find information about open leukemia studies offered at the Johns Hokins Kimmel Cancer Center.

Bone Marrow Transplant Program

The Bone Marrow Transplant (BMT) Program at Johns Hopkins is internationally known and it was a Johns Hopkins researcher, George Santos (1928-2001), who more than 40 years ago, established regimens that would lead to bone marrow transplantation -- the process of taking marrow from a healthy donor and injecting it into a patient.

Bone Marrow Transplant and Haploidentical Transplantation

Dr Rick Jones explains the history of bone marrow transplants, the pioneering scientific discovery lead by Johns Hopkins researchers and the current state of this life saving procedure.